NASDAQ:EQ • US29446K1060
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EQUILLIUM INC (EQ).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-17 | Roth Capital | Reiterate | Buy -> Buy |
| 2026-04-16 | B. Riley Securities | Initiate | Buy |
| 2026-04-14 | Raymond James | Initiate | Strong Buy |
| 2026-03-13 | Roth Capital | Initiate | Buy |
| 2025-03-28 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-11-01 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-08-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-01 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-24 | Stifel | Maintains | Buy |
| 2023-02-08 | SVB Leerink | Maintains | Outperform |
| 2022-09-27 | HC Wainwright & Co. | Maintains | Buy |
| 2022-09-08 | SVB Leerink | Maintains | Outperform |
| 2022-01-05 | SVB Leerink | Maintains | Outperform |
| 2021-09-15 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-03-03 | JonesTrading | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 15.76M | 36.084M 128.96% | 41.095M 13.89% | -100.00% | ||||||
| EBITDA YoY % growth | -61.56M -63.20% | -14.396M 76.61% | -8.132M 43.51% | N/A -189.20% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -61.68M -63.22% | -14.522M 76.46% | -8.269M 43.06% | -25.151M -185.81% | -27.089M -14.62% | -32.288M -19.19% | -31.106M 3.66% | -36.977M -18.87% | -46.762M -26.46% | |
| Operating Margin | -391.37% | -40.24% | -20.12% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -1.18 12.59% | -0.39 66.95% | -0.23 41.03% | -0.42 -117.39% | -0.20 59.83% | -0.25 -23.08% | -0.36 -45.83% | -0.31 14.29% | -0.38 -23.33% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 81.12% | -0.05 71.68% | -0.06 3.87% | -0.07 -80.25% | -0.10 -127.27% | -0.12 -172.73% | -0.10 -78.57% | -0.11 -57.14% |
| Revenue Q2Q % growth | ||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.753M 46.41% | -5.942M 4.60% | -8.126M -77.61% | -9.981M -151.91% | -16.578M -248.78% | -18.863M -217.48% | -21.471M -164.24% | -24.449M -144.96% |
All data in USD
12 analysts have analysed EQ and the average price target is 7.91 USD. This implies a price increase of 265.97% is expected in the next year compared to the current price of 2.16.
EQUILLIUM INC (EQ) will report earnings on 2026-05-12.
The consensus EPS estimate for the next earnings of EQUILLIUM INC (EQ) is -0.05 USD and the consensus revenue estimate is 0 USD.
The consensus rating for EQUILLIUM INC (EQ) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.